Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.

The new JV will manufacture and export a wide range of products including ampoules, nutritional supplements, sterile ...

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Finance Income, net was $1.0 million for the three months ended March 31, 2025, compared to $0.7 million in the same period ...

Indoco Remedies' share price rose after the company received final USFDA approval for its ANDA to market Allopurinol tablets ...

Final CM24 Phase 2 data presented at AACR Annual Meeting 2025, strengthening patient selection strategy for CM24 Phase 2b study planned to be initiated in Second Half of 2025 NT219 data presented at ...

The study abstracts were published on the ASCO website on May 22, 2025 (CDT), with key highlights summarized below: ...

"We are proud to partner with Kaida BioPharma on the development of KAD101,” said Prof. Vladas Algirdas Bumelis, CEO and ...

As part of a delegation of international journalists touring Shandong Province, I arrived in Jinan on Monday for a four-day ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...